FDA Approved Add-On Treatment For Patients With Parkinson’s Disease
According to the National Institutes of Health (NIH), about one million of people in the United States have Parkinson’s disease and about 60,000 people are…
Read MoreProducts
For $14,000 a Year, Cholesterol Drug Repatha (evolocumab) Lowers the Risk of a Heart Attack
FDA Approves House Dust Mite Allergies Treatment Odactra
Spinal Muscular Atrophy Drug Approval
Unreasonable Insulin Price Boost
Painkiller Approval By The FDA
Another Weight-Loss Drug Approval For The Last Month
First Approved Weight-Loss Medication In 13 Years
Experts Are Concerned With The New Strong Painkiller
Lucentis And Avastin Effectiveness In Treating Macular Degeneration
Age-related macular degradation (AMD) is the most common reason for vision loss or blindness in senior U.S. citizens. This disease spurs the growth of uncommon…